BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38220431)

  • 21. The N-myristoylome of Trypanosoma cruzi.
    Roberts AJ; Fairlamb AH
    Sci Rep; 2016 Aug; 6():31078. PubMed ID: 27492267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unveiling the Trypanosoma cruzi Nuclear Proteome.
    dos Santos Júnior Ade C; Kalume DE; Camargo R; Gómez-Mendoza DP; Correa JR; Charneau S; de Sousa MV; de Lima BD; Ricart CA
    PLoS One; 2015; 10(9):e0138667. PubMed ID: 26383644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative proteomic analysis of trypomastigotes from Trypanosoma cruzi strains with different pathogenicity.
    Herreros-Cabello A; Callejas-Hernández F; Fresno M; Gironès N
    Infect Genet Evol; 2019 Dec; 76():104041. PubMed ID: 31536808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative Proteomic Analysis of Replicative and Nonreplicative Forms Reveals Important Insights into Chromatin Biology of Trypanosoma cruzi.
    Leandro de Jesus TC; Calderano SG; Vitorino FN; Llanos RP; Lopes MC; de Araújo CB; Thiemann OH; Reis MD; Elias MC; Chagas da Cunha JP
    Mol Cell Proteomics; 2017 Jan; 16(1):23-38. PubMed ID: 27852749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic analysis of the human pathogen Trypanosoma cruzi.
    Paba J; Santana JM; Teixeira AR; Fontes W; Sousa MV; Ricart CA
    Proteomics; 2004 Apr; 4(4):1052-9. PubMed ID: 15048986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteome analysis of the causative agent of Chagas disease: Trypanosoma cruzi.
    Parodi-Talice A; Durán R; Arrambide N; Prieto V; Piñeyro MD; Pritsch O; Cayota A; Cerveñansky C; Robello C
    Int J Parasitol; 2004 Jul; 34(8):881-6. PubMed ID: 15217726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recently differentiated epimastigotes from Trypanosoma cruzi are infective to the mammalian host.
    Kessler RL; Contreras VT; Marliére NP; Aparecida Guarneri A; Villamizar Silva LH; Mazzarotto GACA; Batista M; Soccol VT; Krieger MA; Probst CM
    Mol Microbiol; 2017 Jun; 104(5):712-736. PubMed ID: 28240790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomics in Trypanosoma cruzi--localization of novel proteins to various organelles.
    Ferella M; Nilsson D; Darban H; Rodrigues C; Bontempi EJ; Docampo R; Andersson B
    Proteomics; 2008 Jul; 8(13):2735-49. PubMed ID: 18546153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exoproteome profiling of Trypanosoma cruzi during amastigogenesis early stages.
    Mandacaru SC; Queiroz RML; Alborghetti MR; de Oliveira LS; de Lima CMR; Bastos IMD; Santana JM; Roepstorff P; Ricart CAO; Charneau S
    PLoS One; 2019; 14(11):e0225386. PubMed ID: 31756194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombination-driven generation of the largest pathogen repository of antigen variants in the protozoan Trypanosoma cruzi.
    Weatherly DB; Peng D; Tarleton RL
    BMC Genomics; 2016 Sep; 17(1):729. PubMed ID: 27619017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteomic changes in Trypanosoma cruzi epimastigotes treated with the proapoptotic compound PAC-1.
    de Castro Andreassa E; Santos MDMD; Wassmandorf R; Wippel HH; Carvalho PC; Fischer JSDG; Souza TACB
    Biochim Biophys Acta Proteins Proteom; 2021 Feb; 1869(2):140582. PubMed ID: 33285319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computational Prediction of Trypanosoma cruzi Epitopes Toward the Generation of an Epitope-Based Vaccine Against Chagas Disease.
    Ros-Lucas A; Rioja-Soto D; Gascón J; Alonso-Padilla J
    Methods Mol Biol; 2023; 2673():487-504. PubMed ID: 37258934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is It Possible to Intervene in the Capacity of
    Ramírez-Toloza G; Aguilar-Guzmán L; Valck C; Menon SS; Ferreira VP; Ferreira A
    Front Immunol; 2021; 12():789145. PubMed ID: 34975884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EIF2α phosphorylation is regulated in intracellular amastigotes for the generation of infective Trypanosoma cruzi trypomastigote forms.
    Castro Machado F; Bittencourt-Cunha P; Malvezzi AM; Arico M; Radio S; Smircich P; Zoltner M; Field MC; Schenkman S
    Cell Microbiol; 2020 Nov; 22(11):e13243. PubMed ID: 32597009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TcTASV: a novel protein family in trypanosoma cruzi identified from a subtractive trypomastigote cDNA library.
    García EA; Ziliani M; Agüero F; Bernabó G; Sánchez DO; Tekiel V
    PLoS Negl Trop Dis; 2010 Oct; 4(10):. PubMed ID: 20957201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Kinetoplastid-Specific Protein TcCAL1 Plays Different Roles During
    Rodríguez-Durán J; Gallardo JP; Alba Soto CD; Gómez KA; Potenza M
    Front Cell Infect Microbiol; 2022; 12():901880. PubMed ID: 35846750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A dataset of proteins associated with
    Márvez ER; Segura CAR; Requena JM; Puerta CJ
    Data Brief; 2022 Apr; 41():107953. PubMed ID: 35242934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of Trypanosoma cruzi SAP proteins with host-cell lysosome exocytosis-inducing activity required for parasite invasion.
    Zanforlin T; Bayer-Santos E; Cortez C; Almeida IC; Yoshida N; da Silveira JF
    PLoS One; 2013; 8(12):e83864. PubMed ID: 24391838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical, immunological, and biological characterization of Trypanosoma cruzi populations of the Andean north of Chile.
    Gonzalez J; Muñoz S; Ortiz S; Anacona D; Salgado S; Galleguillos M; Neira I; Sagua H; Solari A
    Exp Parasitol; 1995 Aug; 81(1):125-35. PubMed ID: 7628560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Trypanosoma cruzi with 2-bromopalmitate alters morphology, endocytosis, differentiation and infectivity.
    Batista CM; Kessler RL; Eger I; Soares MJ
    BMC Cell Biol; 2018 Aug; 19(1):19. PubMed ID: 30170543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.